Thursday, September 28, 2023
HomeLatest Pharma-News

Latest Pharma-News

Latest Pharma-News

Farxiga extended in US to reduce risk of cardiovascular death and hospitalisation for heart failure to a broader range of patients

admin - 0
Latest Pharma-News

BMS Receives EC Approval for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy

admin - 0
Latest Pharma-News

Koselugo approved in China for paediatric patients with neurofibromatosis type 1 and plexiform neurofibromas

admin - 0
Latest Pharma-News

FDA Takes Additional Steps to Advance Decentralized Clinical Trials

admin - 0
Latest Pharma-News

FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine

admin - 0
Latest Pharma-News

Bayer and Cat Creek Energy Sign Landmark Renewable Energy Deal

admin - 0
Latest Pharma-News

Sandoz to exclusively commercialize six products in the US, reinforcing global leadership position in off-patent medicines

admin - 0
Latest Pharma-News

XTANDI® plus Leuprolide Reduced the Risk of Metastasis by 58% in Non-Metastatic Hormone-Sensitive Prostate Cancer versus Placebo plus Leuprolide

admin - 0
Latest Pharma-News

Update on FDA Advisory Committee vote on Lynparza plus abiraterone for metastatic castration-resistant prostate cancer

admin - 0
Latest Pharma-News

EMA validates marketing authorisation application for Jemperli plus chemotherapy for dMMR/MSI-H primary advanced or recurrent endometrial cancer

admin - 0
Latest Pharma-News

FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines

admin - 0
Latest Pharma-News

Bayer’s New data from pivotal studies with aflibercept 8 mg

admin - 0
123...144Page 1 of 144
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved